BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 24040201)

  • 21. The transcription factor Cas5 suppresses hyphal morphogenesis during yeast-form growth in Candida albicans.
    Kim JM; Moon HY; Lee DW; Kang HA; Kim JY
    J Microbiol; 2021 Oct; 59(10):911-919. PubMed ID: 34491522
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Resveratrol impaired the morphological transition of Candida albicans under various hyphae-inducing conditions.
    Okamoto-Shibayama K; Sato Y; Azuma T
    J Microbiol Biotechnol; 2010 May; 20(5):942-5. PubMed ID: 20519919
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Secondary Metabolites from Food-Derived Yeasts Inhibit Virulence of Candida albicans.
    Kunyeit L; Kurrey NK; Anu-Appaiah KA; Rao RP
    mBio; 2021 Aug; 12(4):e0189121. PubMed ID: 34399611
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Magnesium deprivation affects cellular circuitry involved in drug resistance and virulence in Candida albicans.
    Hans S; Fatima Z; Hameed S
    J Glob Antimicrob Resist; 2019 Jun; 17():263-275. PubMed ID: 30659981
    [TBL] [Abstract][Full Text] [Related]  

  • 25.
    Çolak A; Ikeh MAC; Nobile CJ; Baykara MZ
    mSphere; 2020 Nov; 5(6):. PubMed ID: 33148826
    [No Abstract]   [Full Text] [Related]  

  • 26. (1-aryloxy-2-hydroxypropyl)-phenylpiperazine derivatives suppress Candida albicans virulence by interfering with morphological transition.
    Zhao S; Huang JJ; Sun X; Huang X; Fu S; Yang L; Liu XW; He F; Deng Y
    Microb Biotechnol; 2018 Nov; 11(6):1080-1089. PubMed ID: 30221456
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antifungal activity and influence of propolis against germ tube formation as a critical virulence attribute by clinical isolates of Candida albicans.
    Haghdoost NS; Salehi TZ; Khosravi A; Sharifzadeh A
    J Mycol Med; 2016 Dec; 26(4):298-305. PubMed ID: 27789229
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of loureirin A against Candida albicans biofilms.
    Lin MY; Yuan ZL; Hu DD; Hu GH; Zhang RL; Zhong H; Yan L; Jiang YY; Su J; Wang Y
    Chin J Nat Med; 2019 Aug; 17(8):616-623. PubMed ID: 31472899
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulation of phagosomal pH by Candida albicans promotes hyphal morphogenesis and requires Stp2p, a regulator of amino acid transport.
    Vylkova S; Lorenz MC
    PLoS Pathog; 2014 Mar; 10(3):e1003995. PubMed ID: 24626429
    [TBL] [Abstract][Full Text] [Related]  

  • 30.
    Graham CE; Cruz MR; Garsin DA; Lorenz MC
    Proc Natl Acad Sci U S A; 2017 Apr; 114(17):4507-4512. PubMed ID: 28396417
    [No Abstract]   [Full Text] [Related]  

  • 31. Potent Activities of Roemerine against Candida albicans and the Underlying Mechanisms.
    Ma C; Du F; Yan L; He G; He J; Wang C; Rao G; Jiang Y; Xu G
    Molecules; 2015 Sep; 20(10):17913-28. PubMed ID: 26426004
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of plant-derived saponin natural products against Candida albicans.
    Coleman JJ; Okoli I; Tegos GP; Holson EB; Wagner FF; Hamblin MR; Mylonakis E
    ACS Chem Biol; 2010 Mar; 5(3):321-32. PubMed ID: 20099897
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 5-hydroxymethyl-2-furaldehyde from marine bacterium Bacillus subtilis inhibits biofilm and virulence of Candida albicans.
    Subramenium GA; Swetha TK; Iyer PM; Balamurugan K; Pandian SK
    Microbiol Res; 2018 Mar; 207():19-32. PubMed ID: 29458854
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activity of coumarin against Candida albicans biofilms.
    Xu K; Wang JL; Chu MP; Jia C
    J Mycol Med; 2019 Apr; 29(1):28-34. PubMed ID: 30606640
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of Biofilm Formation by
    Lee JH; Kim YG; Khadke SK; Yamano A; Watanabe A; Lee J
    ACS Infect Dis; 2019 Jul; 5(7):1177-1187. PubMed ID: 31055910
    [No Abstract]   [Full Text] [Related]  

  • 36. Terpenoids of plant origin inhibit morphogenesis, adhesion, and biofilm formation by Candida albicans.
    Raut JS; Shinde RB; Chauhan NM; Karuppayil SM
    Biofouling; 2013; 29(1):87-96. PubMed ID: 23216018
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyclooxygenase inhibitors reduce biofilm formation and yeast-hypha conversion of fluconazole resistant Candida albicans.
    Abdelmegeed E; Shaaban MI
    J Microbiol; 2013 Oct; 51(5):598-604. PubMed ID: 24037655
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic Analysis of Sirtuin Deacetylases in Hyphal Growth of
    Zhao G; Rusche LN
    mSphere; 2021 May; 6(3):. PubMed ID: 33952658
    [No Abstract]   [Full Text] [Related]  

  • 39. The antibacterial agent, moxifloxacin inhibits virulence factors of Candida albicans through multitargeting.
    Jadhav A; Bansode B; Phule D; Shelar A; Patil R; Gade W; Kharat K; Karuppayil SM
    World J Microbiol Biotechnol; 2017 May; 33(5):96. PubMed ID: 28409362
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of inhibitors of yeast-to-hyphae transition in Candida albicans by a reporter screening assay.
    Heintz-Buschart A; Eickhoff H; Hohn E; Bilitewski U
    J Biotechnol; 2013 Mar; 164(1):137-42. PubMed ID: 23262131
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.